Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness analysis using real world data msbase registry comparing natalizum 2
… of Business Development at GE Healthcare in its Clinical Data Services group, UnitedHealthcare's i3 Drug Safety … pharmaceutical, biotech, and device companies to develop real-world evidence solutions and strategy development. …
… natural history of disease, and clinical epidemiology/real-world evidence. Dr. Mines previously worked as a Senior … postapproval settings. His research has involved studies using automated administrative health care data and …
Integrated Evidence Generation Strategy Long-Range Planning for Improved Alignment and Efficiency Biopharma companies have long relied on planning exercises to help inform their product development process. But traditional approaches have their …
… and contributed to the Statistical Methods group of the Real-World Evidence Task Force. Additionally, Dr. Pajouheshnia …
… safety studies, analyses of health-related quality of life data, and analyses of data from population-based surveys … include preparing of protocols and statistical analysis plans; providing statistical analysis support; … writing and reviewing study reports; and developing publications. Ms. Garbinsky is proficient in programming with …
… 2030. And yes, line or label extensions, known as type 2 variations at the EMA, also are included in the … trials, and there are other factors as well. Chapter 2 How is the pharmaceutical industry responding to these new …
… scoring 100 in the Disability Equality Index® (DEI), the world’s most comprehensive benchmarking tool to measure …
… Solutions. Mr. Nangia has over 4 years of experience in data analytics and systematic literature reviews. Specifically, he has experience in direct meta-analysis, utility analysis, and indirect treatment … comparisons. He has led and performed analyses to support publications and/or HTA submissions in various markets. Mr. …
… NC Brian Calingaert, MS, is a Director of Epidemiology Analysis in the Pharmacoepidemiology and Risk Management division of RTI-HS. He has experience in data management and analysis, creation of statistical … studies, including building statistical models using logistic regression and proportional hazards …
… extensive background in mathematical modeling and decision analysis across the healthcare system. Over more than a … with RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his …